UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipid profiles of plants and soil microbial communities are shaped by soil parent material in Australian sclerophyll forests

Plant and soil, 2024-05, Vol.498 (1-2), p.39-55

2024

Volltextzugriff (PDF)

Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia : impact on severity, neuropsychological status, and quality of life

Journal of neurosurgery, 2007-07, Vol.107 (1), p.29-36

2007

Volltextzugriff (PDF)

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

The American journal of psychiatry, 2017-05, Vol.174 (5), p.476-484

2017

Volltextzugriff (PDF)

Toward a Theory of Sympathetic Leadership: Asian American School Administrators’ Expectations for Justice and Excellence

Educational administration quarterly, 2021-08, Vol.57 (3), p.403-436

2021

Volltextzugriff (PDF)

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2015-02, Vol.313 (6), p.584

2015

Volltextzugriff (PDF)

I Am More Than What I Look Alike: Asian American Women in Public School Administration

Educational administration quarterly, 2017-02, Vol.53 (1), p.40-69

2017

Volltextzugriff (PDF)

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study

The journal of clinical psychiatry, 2017-11, Vol.78 (9), p.1344-1350

2017

Volltextzugriff (PDF)

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

Neurology, 2022-01, Vol.98 (1), p.e40

2022

Volltextzugriff (PDF)

The Role of Hypoxia-Inducible Factor in Wound Healing

Advances in wound care (New Rochelle, N.Y.), 2014-05, Vol.3 (5), p.390-399

2014

Volltextzugriff (PDF)

Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease

PloS one, 2017-08, Vol.12 (8), p.e0183874-e0183874

2017

Volltextzugriff (PDF)

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

Movement disorders, 2019-08, Vol.34 (8), p.1203-1209

2019

Volltextzugriff (PDF)

OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2

Parkinsonism & related disorders, 2024-06, Vol.123, p.106971, Article 106971

2024

Volltextzugriff (PDF)

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

Neurology, 2022-08, Vol.99 (6), p.260-261

2022

Volltextzugriff (PDF)

Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa

Clinical neuropharmacology, 2023-03, Vol.46 (2), p.43

2023

Volltextzugriff (PDF)

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

Neurology, 2022-08, Vol.99 (6), p.259-259

2022

Volltextzugriff (PDF)

Single-Cell Transcriptional Profiling Reveals Sex and Age Diversity of Gene Expression in Mouse Endothelial Cells

Frontiers in genetics, 2021-02, Vol.12, p.590377-590377

2021

Volltextzugriff (PDF)

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Journal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.620-627

2019

Volltextzugriff (PDF)

Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials

Drug safety, 2018-04, Vol.41 (4), p.429-440

2018

Volltextzugriff (PDF)

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

JAMA neurology, 2014-06, Vol.71 (6), p.710

2014

Volltextzugriff (PDF)

Severe neuropathy with leaky connexin32 hemichannels

Annals of neurology, 2005-05, Vol.57 (5), p.749-754

2005

Volltextzugriff (PDF)

A long-term, open-label study of valbenazine for tardive dyskinesia

CNS spectrums, 2021-08, Vol.26 (4), p.345-353

2021

Volltextzugriff (PDF)

Development of a Bayesian inference model for assessing ventilation condition based on CO2 meters in primary schools

Building simulation, 2023-01, Vol.16 (1), p.133-149

2023

Volltextzugriff (PDF)

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results from the KINECT 3 Study

The journal of clinical psychiatry, 2018-12, Vol.80 (1)

2018

Volltextzugriff (PDF)

Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers

JACC. Cardiovascular imaging, 2015-08, Vol.8 (8), p.873-884

2015

Volltextzugriff (PDF)

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort

Journal of the neurological sciences, 2017-06, Vol.377, p.137-143

2017

Volltextzugriff (PDF)

1 – 25 von 630

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(557)
Mit Volltextzugriff
(518)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(375)
Life Sciences & Biomedicine
(292)
Humans
(214)
Male
(110)
Female
(106)
Middle Aged
(77)
Aged
(66)
Adult
(57)
Technology
(51)
Animals
(46)
Gastroenterology & Hepatology
(43)
Physical Sciences
(43)
Neurosciences & Neurology
(39)
Risk Factors
(33)
Science & Technology - Other Topics
(33)
Clinical Neurology
(31)
Patients
(31)
Engineering
(27)
Hepatitis B
(27)
Biological And Medical Sciences
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(24)
Neurology
(24)
Journal Of Vascular Surgery
(13)
Cancer Research
(10)
Nature Communications
(9)
Hepatology
(8)
Movement Disorders
(8)
Plos One
(8)
Alimentary Pharmacology & Therapeutics
(6)
Clinical And Molecular Hepatology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Lipid profiles of plants and soil microbial communities are shaped by soil parent material in Australian sclerophyll forests

Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia : impact on severity, neuropsychological status, and quality of life

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

Toward a Theory of Sympathetic Leadership: Asian American School Administrators’ Expectations for Justice and Excellence

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

I Am More Than What I Look Alike: Asian American Women in Public School Administration

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

The Role of Hypoxia-Inducible Factor in Wound Healing

Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

Single-Cell Transcriptional Profiling Reveals Sex and Age Diversity of Gene Expression in Mouse Endothelial Cells

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

Severe neuropathy with leaky connexin32 hemichannels

A long-term, open-label study of valbenazine for tardive dyskinesia

Development of a Bayesian inference model for assessing ventilation condition based on CO2 meters in primary schools

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results from the KINECT 3 Study

Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort

Suchergebnisse filtern